These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39692942)
1. Evaluating the effect of acute myeloblastic leukemia-derived exosomes on the human bone marrow mesenchymal stromal cell proliferation. Kuhestani-Dehaghi B; Amirpour M; Nabigol M; Keshavarz A; Vazifeh Shiran N; Rahmani-Seraji H; Dehghani-Ghorbi M; Allahbakhshian Farsani M Mol Biol Rep; 2024 Dec; 52(1):62. PubMed ID: 39692942 [TBL] [Abstract][Full Text] [Related]
2. The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia's biological functions: a focus on the potential role of LncRNAs. Jalilivand S; Izadirad M; Vazifeh Shiran N; Gharehbaghian A; Naserian S Clin Exp Med; 2024 May; 24(1):108. PubMed ID: 38777995 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from minor salivary gland mesenchymal stem cells: a promising novel exosome exhibiting pro-angiogenic and wound healing effects similar to those of adipose-derived stem cell exosomes. Xiang H; Ding P; Qian J; Lu E; Sun Y; Lee S; Zhao Z; Sun Z; Zhao Z Stem Cell Res Ther; 2024 Dec; 15(1):462. PubMed ID: 39627883 [TBL] [Abstract][Full Text] [Related]
5. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
6. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
7. Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis. Aldin A; Baumeister PhD A; Chakraverty D; Monsef I; Noyes J; Kalbe E; Woopen C; Skoetz N Cochrane Database Syst Rev; 2024 Dec; 12(12):CD013302. PubMed ID: 39665382 [TBL] [Abstract][Full Text] [Related]
8. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Yi J; Ye Z; Xu H; Zhang H; Cao H; Li X; Wang T; Dong C; Du Y; Dong S; Zhou W Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403 [TBL] [Abstract][Full Text] [Related]
9. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways. Zhang C; Li W; Wu F; Lu Z; Zeng P; Luo Z; Cao Y; Wen F; Li J; Chen X; Wang F Ther Adv Hematol; 2024; 15():20406207241301948. PubMed ID: 39610460 [TBL] [Abstract][Full Text] [Related]
10. "Cellularity as a predictive tool for mesenchymal stem cell concentration in bone marrow concentrates: Implications for regenerative medicine". Labarre KW; Grathwol PA; Zimmermann G Bone Rep; 2025 Mar; 24():101820. PubMed ID: 39691445 [TBL] [Abstract][Full Text] [Related]
11. The effect of sample site and collection procedure on identification of SARS-CoV-2 infection. Davenport C; Arevalo-Rodriguez I; Mateos-Haro M; Berhane S; Dinnes J; Spijker R; Buitrago-Garcia D; Ciapponi A; Takwoingi Y; Deeks JJ; Emperador D; Leeflang MMG; Van den Bruel A; Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014780. PubMed ID: 39679851 [TBL] [Abstract][Full Text] [Related]
12. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
13. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults. Love AMA; Edwards C; Cai RY; Gibbs V Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059 [TBL] [Abstract][Full Text] [Related]
14. [Preparation of a dual-specific antibody targeting human CD123 and exploration of its anti-acute myeloid leukemia effects]. Zhou T; Chen ML; Zhang CY; Liu XY; Wang ZZ; Xing HY; Tang KJ; Tian Z; Rao Q; Wang M; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):225-232. PubMed ID: 38716593 [No Abstract] [Full Text] [Related]
15. Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent Mechanism. Wang C; Song R; Yuan J; Hou G; Chu AL; Huang Y; Xiao C; Chai T; Sun C; Liu Z Drug Dev Res; 2025 Feb; 86(1):e70025. PubMed ID: 39690960 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review. O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303 [TBL] [Abstract][Full Text] [Related]
17. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline. Reece D; Imrie K; Stevens A; Smith CA; Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013 [TBL] [Abstract][Full Text] [Related]
18. B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies. Lee S; Chae SJ; Jang IH; Oh SC; Kim SM; Lee SY; Kim JH; Ko J; Kim HJ; Song IC; Kim JK; Kim TD EBioMedicine; 2024 Dec; 110():105459. PubMed ID: 39579618 [TBL] [Abstract][Full Text] [Related]